Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate: a Phase IV, Multicenter, Randomized, Double-blind, Controlled Trial

NCT02313922 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT02313922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02313922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate: a Phase IV, Multicenter, Randomized, Double-blind, Controlled Trial
Lead sponsor
Zhejiang University
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2014
Completion date
August 31, 2018
Enrollment
466 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis